Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 805

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 7A
Chunk 805
---
  
     - 

    Michelle
    Yanez 
     20,000  
     -  
     -  
    $6.50  
    8/16/33 
     -  
     -  
     -  
     - 

     15,556  
     31,111  
     -  
    $5.00  
    4/27/33 
     -  
     -  
     -  
     - 

     6,667  
     3,333  
     -  
    $5.00  
    6/14/32 
     -  
     -  
     -  
     - 

     75,000  
     75,000  
     -  
    $1.16  
    3/25/34 
     -  
     -  
     -  
     - 

     -  
     150,000  
     -  
    $1.19  
    12/6/34 
     -  
     -  
     -  
     - 

74

Option
Exercises and Stock Vested

No
stock options were exercised by our executive officers during the year ended December 31, 2024.

2022
Omnibus Incentive Plan

Our
board of directors has adopted, and our stockholders have approved, our 2022 Omnibus Incentive Plan, or the 2022 Omnibus Plan. The 2022
Omnibus Plan authorizes the grant of incentive stock options, within the meaning of Section 422 of the Internal Revenue Code, to our
employees and any of our parent and subsidiary corporations’ employees, and the grant of nonstatutory stock options, restricted
stock, restricted stock units, stock appreciation rights, performance units and performance shares to our employees, directors, and consultants
and any of our future subsidiary corporations’ employees and consultants. The following is a summary of certain terms and conditions
of the 2022 Omnibus Plan. This summary is qualified in its entirety by reference to the 2022 Omnibus Plan attached as an exhibit to this
Report.

Administration

The
2022 Omnibus Plan is administered by